Interestingly in a Portuguese primary care-based cohort, BIN1 rs744373 risk-allele carriers were found to have a lower risk of dyslipidemia and respiratory diseases, while tending to have an increased risk of type 2 diabetes [29]. This evidence concerns the gene BIN1 and metabolic syndrome.